For CY 2025, HCPCS code G0566 was assigned to APC 5721 (Level 1 Diagnostic Tests and Related Services) with the status indicator S (separate APC payment)
This volume is excellent for beginners or anyone who prioritizes dosing accuracy over injection volume
Specifically, it produces no IGF-1 elevation (avoiding proliferative concerns), no negative impact on glucose metabolism (avoiding diabetes risk), no fluid retention or edema, and no concerning patterns of joint pain that can occur with growth hormone
Lipotropic injections: Cost, dosage, and risks
That doesn't mean every oral-capsule purchase is wasted it means the published pharmacology gives no support to expecting the mouse-data effects from oral product
Before committing to either, knowing your baseline NAD+ level tells you whether NAD+ deficiency is part of what youre dealing with, which changes how any protocol should be sequenced